U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07143968) titled 'A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV' on Aug. 25.
Brief Summary: The purpose of this research study is to test the safety and effectiveness of the study drug, resmetirom, in participants with MASLD and HIV. This is a research study to test a drug that is already on the market with a population that was not included in the original clinical trials. Participants will be people over age 18 with HIV who are on antiretroviral therapy and have been diagnosed with MASLD.
Researchers will compare resmetirom to placebo (a look-alike substance that contains no drug) to see if resmetirom decreases the a...